Souhaitez-vous accéder aux communiqués récents ?

Today, 20 March 2020, the Board of Directors approved the Annual Report for 2019. Please find the Annual Report, including the ESG Report (chapter 5) for 2019 attached. For further...

Ålesund/London, 17.03.2020 Hofseth BioCare (“HBC”) has today signed a comprehensive distribution contract with Prinova Europe (“Prinova”). The agreement is a European exclusive distribution...

James Berger, Head of Investor Relations & Strategy in Hofseth BioCare ASA, has today 26.02.2020 purchased 30,000 shares at an average price of NOK 6,73 per share. Following this transaction,...

Hofseth BioCare ASA ("HBC") had operating revenues of NOK 11.1m (NOK 14.5m) in the fourth quarter of 2019. Cost of Goods Sold (CoGS) amounted to NOK 8.4m (NOK 9.9m) in the period. Operational profit...

Today, Hofseth BioCare ASA (“HBC”) has signed a new credit facility of up to NOK 37 million with SpareBank 1 Nordvest for working capital needs related to future sales contracts. The credit line is...

On January 1, 2020, a merger between Yokohama Reito Co., Ltd. ("Yokorei") and its wholly owned subsidiary, Alliance Seafoods Inc., the latter being the owner of 40,951,333 shares in Hofseth Biocare...

Ålesund/Miami, November 1st, 2019 Atlantic Sapphire AS (“Atlantic Sapphire”, ASA-ME) and Hofseth Biocare ASA (“HBC”; OSE:HBC) announce today the signing of a Letter of Intent to establish a joint...

Hofseth BioCare had operating revenues of NOK 29.2m (16.9m) in the third quarter of 2019. Cost of Goods Sold (CoGS) amounted to NOK 25.3m (14.3m) in the period. Operational profit (EBITDA) for...

Hofseth BioCare ASA ("HBC") has entered into a consultancy agreement with Dr. Crawford Currie to strengthen the IR and communications functions of HBC. Dr. Currie is based in London and is a...

Hofseth BioCare ASA ("HBC") has today entered into a consultancy agreement with James Berger (through his company Nevera AG). Mr. Berger is a dual British and Italian citizen currently residing in...